Bayer Polymers to discontinue Cobalt-polybutadiene (CoBR) production in Marl
Reason for decision: drastic drop in demand for CoBR
Bayer Polymers, a division of Bayer AG, is planning to discontinue the production of Cobalt-polybutadiene (CoBR) at its subsidiary Bayer Buna GmbH in Marl in the first half of 2004. The reason for this decision is primarily the accelerating drop in demand for this rubber product. The CoBR facility has a total capacity of 45,000 metric tons. Some 75 employees will be affected. The company has started an information and consultation process with the works council and in the coming weeks will be working on finding individual solutions for those involved. Bayer Buna GmbH currently employs around 240 people in Marl. The production of EPDM rubber which also takes place in Marl is unaffected.
BR from Marl serves as a general-purpose rubber in tires and, in particular, as a plastics modifier for the manufacture of High Impact Polystyrene (HIPS), which is used in packaging materials and a variety of other applications. Owing to increasing substitution of CoBR by Lithium-polybutadiene (LiBR) in the HIPS application, production volumes have fallen drastically. "Closing the facility is therefore an absolute necessity in view of our strategy to improve profitability. Given the structural changes in the market, we see no possibility of continuing CoBR production in Marl," said Dr. Joachim Grub, Head of BR / Butyl Global Operations at Bayer Polymers.
Bayer Polymers will concentrate its remaining polybutadiene production at its sites in Orange (Texas, USA), Port Jérôme (France) and Dormagen (Germany).
Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjuste ... more
BASF has closed the acquisition of a range of businesses and assets from Bayer. The transaction is a strategic complement to BASF’s crop protection, biotech and digital farming activities and marks its entry into seeds, non-selective herbicides and nematicide seed treatments.
“This strategi ... more
In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically. “We took major steps toward the proposed acquisition of Monsanto,” Management Board Chairman Werner Baumann said on Wednesday at the Financial News Conference in Leverkusen. Phar ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more